|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.4800 - 0.5990|
|52 Week Range||0.2200 - 1.3100|
|Beta (3Y Monthly)||-1.16|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
DENVER, CO, Dec. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Cannabis Company, Inc. (AMMJ) (“ACC”), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, commented today on the filing of its Form 10-K for the year ended December 31, 2017 with the Securities and Exchange Commission on December 26, 2018. Mr. Terry Buffalo, the Company’s Principal Executive Officer, commented: “I am happy to announce this filing. The Company ran into significant headwinds that caused it to be late with its annual report for last year, including the death of our CFO’s wife at the start of the audit process, and the resulting difficulties caused by our auditor not having conducted a previous audit of our Company.
With the previous presidential administration’s frankness on the matter, marijuana has become more blasé. Naturally, marijuana stocks have also increased in popularity, where we have more choices today than was previously thought possible. For instance, some of the top marijuana stocks are levered toward medical cannabis.
NEW YORK , June 6, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lists of downgrades from its respective ...
According to a report by Ameri Research Inc., the global legal cannabis market was valued at $14.3 billion in 2016 and is estimated to grow at a CAGR of 21.1% between 2017 to 2024, while reaching a value of $63.5 billion by 2024. The market is going through a period of robust growth because of increasing legalization and decriminalization of cannabis products across North America. Data by Arcview Market Research clarifies that growth of the legal cannabis industry are expected reaccelerate in 2018, as adult use sales ramp up in Canada, California, and Massachusetts along with medical sales in Florida.